Five things to know:
1. Copay cards and coupons have become a popular marketing strategy offered by drug manufacturers.The coupons cut patients’ out-of-pocket costs to promote branded medications — particularly those facing cheap alternatives — ultimately promising consumers savings at the pharmacy counter.
2. Pfizer’s coupons stated that consumers would “pay no more than” $15 to $25 for certain medications. However, patients were often required to pay much more because of limits that were not prominently disclosed on the coupon.
3. Pfizer’s $975,000 payment will resolve charges brought by the Oregon Justice Department.
4. The state Justice Department identified 371 customers who collectively paid about $40,000 more than the amount promised by the coupon the first time a prescription was filled, according to the settlement filing.
5. This is the second time that Pfizer paid to resolve coupon deception charges. Last October, Pfizer settled with New York for $700,000.
More articles on pharmacy:
Bristol-Myers urges shareholders to support Celgene takeover
Novartis to pay $23M to settle claims it used charity payments as kickbacks
Martin Shkreli reportedly running his pharma company from prison
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.